Advertisement
Screener

ACCURAY INCORPORATED (ARAY) Provision for Loan, Lease, and Other Losses

1.5 / 5 stars · 30/102 Roast Me

ACCURAY INCORPORATED Provision for Loan, Lease, and Other Losses

ACCURAY INCORPORATED (ARAY) reported Provision for Loan, Lease, and Other Losses of $573.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2026-08-27

  • ACCURAY INCORPORATED provision for loan, lease, and other losses for the quarter ending 2026-06-30 was -$29.00K.
  • ACCURAY INCORPORATED provision for loan, lease, and other losses for the quarter ending 2026-03-31 was -$61.00K.
  • ACCURAY INCORPORATED provision for loan, lease, and other losses for the quarter ending 2025-12-31 was -$22.00K, a 146.81% decline year-over-year.
  • ACCURAY INCORPORATED provision for loan, lease, and other losses for the quarter ending 2025-09-30 was $685.00K, a 180.74% increase year-over-year.
  • ACCURAY INCORPORATED provision for loan, lease, and other losses for fiscal 2026 was $573.00K.
  • ACCURAY INCORPORATED provision for loan, lease, and other losses for fiscal 2025 was -$101.00K.
  • ACCURAY INCORPORATED provision for loan, lease, and other losses for fiscal 2024 was -$479.00K.
Period endProvision for Loan, Lease, and Other Losses 3 monthProvision for Loan, Lease, and Other Losses 6 monthProvision for Loan, Lease, and Other Losses 9 monthProvision for Loan, Lease, and Other Losses 12 month
2026-06-30-$29.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
-$90.00K
derived: sum of 2 quarters · filed 2026-08-27
-$112.00K
derived: sum of 3 quarters · filed 2026-08-27
$573.00K
10-K · filed 2026-08-27
2026-03-31-$61.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
-$83.00K
derived: sum of 2 quarters · filed 2026-05-06
$602.00K
10-Q · filed 2026-05-06
$455.00K
derived: sum of 4 quarters · filed 2026-08-27
2025-12-31-$22.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-17
$663.00K
10-Q · filed 2026-02-17
$516.00K
derived: sum of 3 quarters · filed 2026-08-27
$271.00K
derived: sum of 4 quarters · filed 2026-08-27
2025-09-30$685.00K
10-Q/A · filed 2026-02-17
$538.00K
derived: sum of 2 quarters · filed 2026-08-27
$293.00K
derived: sum of 3 quarters · filed 2026-08-27
$340.00K
derived: sum of 4 quarters · filed 2026-08-27
2025-06-30-$147.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
-$392.00K
derived: sum of 2 quarters · filed 2026-08-27
-$345.00K
derived: sum of 3 quarters · filed 2026-08-27
-$101.00K
10-K · filed 2026-08-27
2025-03-31-$245.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
-$198.00K
derived: sum of 2 quarters · filed 2026-05-06
$46.00K
10-Q · filed 2026-05-06
2024-12-31$47.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-17
$291.00K
10-Q · filed 2026-02-17
2024-09-30$244.00K
10-Q/A · filed 2026-02-17
2024-06-30-$479.00K
10-K/A · filed 2026-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Glucotrack, Inc. (GCTK)United States$0.027B
PAVmed Inc. (PAVM)United States$0.031B-3.00
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
InspireMD, Inc. (NSPR)$0.033B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10